Navigation Links
Cetero Research Names 25-Year Industry Veteran James Dixon to Head Quality and Compliance

CARY, N.C., April 26, 2011 /PRNewswire/ -- Cetero Research, the leading early-stage contract research organization (CRO), today announced the appointment of James "Jay" Dixon to Senior Vice President, Quality and Compliance. Dixon has spent more than 25 years in the pharmaceutical, biotechnology and CRO industries, and will bring his extensive experience to support Cetero's objective of maintaining its market leadership position.

(Photo: )

At Cetero, Dixon will lead the Quality and Compliance team, ensuring that Cetero's unwavering commitment to quality provides its clients with the most dependable and accurate results.

"We are thrilled to have someone of Jay's caliber joining the Cetero team," said CEO Troy W. McCall, Ph.D. "Cetero considers quality and compliance to be the utmost priority. Jay's qualifications and background will undoubtedly help raise Cetero's benchmark for quality to an unprecedented new level."

Dixon's career has focused on clinical (GCP), preclinical (GLP), manufacturing (GMP) quality, medical operations and analytical chemistry. Dixon most recently led the quality and compliance efforts for MedImmune, LLC, as Vice President of GxP Quality Compliance. Prior to that, he was at Covance Central Laboratory Services as Vice President of Global Quality Assurance and Business Process Improvement – Six Sigma.

"Quality, safety and consistency are more important than ever in our industry," Dixon said. "I am committed to building upon Cetero's reputation as the leader in early-stage clinical research and to further improving on our record of high-quality performance and reliability."

Prior to his work at Covance, Dixon also held quality-focused leadership positions at Abbott Laboratories, Inc., Triangle Pharmaceuticals (now Gilead Sciences), PAREXEL International Corporation, ClinTrials Research, Inc., Glaxo, Inc. and Glaxo Wellcome, Inc. Dixon holds a bachelor's degree in biology from Campbell University in North Carolina. He is a member of the Board of Directors of Frederick Memorial Healthcare System in Frederick, Maryland, the Drug Information Association (DIA) and the Society of Quality Assurance (SQA).

About Cetero Research

Cetero Research, the leading early-phase contract research organization (CRO), has conducted more than 20,000 clinical pharmacology studies, more than any other CRO. With facilities across North America, Cetero offers flexible, high-quality clinical development services in a range of therapeutic areas, including asthma and allergy, dermatology and diabetes, as well as bioanalytical services to support clinical, preclinical drug and biomarker analysis for small and large molecules. It uses innovative approaches, such as the Accelerated Proof-of-Concept study design to provide key decision-making data earlier in the development process. A pioneer in the pharmaceutical and biotechnology industries, Cetero prioritizes ensuring the safety of its patient and normal healthy study participants, reporting high-quality, reliable data and providing on-time results. For more information, visit or call 877.7CETERO

SOURCE Cetero Research
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cetero Research Leads Industry in Human Allergy Models
2. Cetero Research Launches Seminar Series on Accelerated Proof-of-Concept in Drug Development
3. Cetero Research Names Dr. Roger Hayes President of Bioanalytical Operations
4. Cetero Research Announces Completion of 20,000th Early-Phase Clinical Study
5. Cetero Research Seminars Provide Insights on Designing Accelerated Proof-of-Concept Studies
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
9. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
10. Video: New Research Discovers Independent Brain Networks Control Human Walking
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
(Date:12/1/2015)... , Dec. 01, 2015 ... the addition of the "Medium Molecular ... Sealants, Lubricants, and Other Applications - Global ... Forecast, 2015 - 2023" report to ... has announced the addition of the ...
(Date:12/1/2015)... 2015 WellStar Health System has signed a ... -based Tenet Healthcare,s five metro Atlanta ... strategic move following the conclusion of the due diligence ... models and patient safety programs that have resulted in ... communities. --> --> ...
(Date:12/1/2015)... , Dec. 01, 2015 ... addition of the "Spinal Muscular Atrophy ... and Forecast 2015 - 2023" report ... ) has announced the addition of the ... Assessment, Size, Growth, Trends, and Forecast 2015 ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... Califia Farms , one of the ... bottle has won top honors in Beverage World Magazine’s Global Packaging Design Awards, taking ... it has been selected as a 2015 U.S.A. Taste Champion in the American Masters ...
(Date:12/1/2015)... ... December 01, 2015 , ... December ... the expansion of the company’s growing product line of food safety and seafood ... and Sockeye (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable species identification ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... have been lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s first ... Annual Meeting from November 29 to December 4, 2015. , MED-TAB is ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... is everything. That is why Hollister Incorporated has launched the VaPro Plus Pocket™ ... next product in the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice ...
(Date:12/1/2015)... ... 01, 2015 , ... McLean, VA., December 1, 2015 - ... per sprint agile development contract to support the National Geospatial-Intelligence Agency's (NGA) IT ... software engineering, infrastructure, as well as operations and sustainment support to the NGA’s ...
Breaking Medicine News(10 mins):